Book now
Home / Answers / What is the difference between semaglutide and tirzepatide?
Answers · Beauty Me MD

What is the difference between semaglutide and tirzepatide?

Short answerSemaglutide and tirzepatide are both prescription weekly injections that reduce appetite and help regulate blood sugar. Semaglutide, sold as Wegovy and Ozempic, activates one receptor, GLP-1. Tirzepatide, sold as Zepbound and Mounjaro, is a dual agonist that activates GLP-1 and GIP. Both share similar side effects, and a licensed prescriber decides which fits you.

Semaglutide mimics GLP-1, a gut hormone that signals fullness, slows stomach emptying and helps control blood sugar. Ozempic and Wegovy contain the same molecule: Ozempic was originally approved for type 2 diabetes, and Wegovy is approved for chronic weight management.

Tirzepatide works in a similar way but also activates the GIP receptor, which is why it is called a dual agonist. Mounjaro is approved for type 2 diabetes, and Zepbound is the brand approved for chronic weight management.

Both medications can cause nausea, vomiting, diarrhea, constipation, bloating, headache, fatigue and dizziness, especially when starting or increasing the dose. Neither is suitable for people with a personal or family history of medullary thyroid cancer or MEN2, or during pregnancy.

At Beauty Me MD in Westwood, the choice is made after a consultation, a body composition scan and a medical review of your goals and history.

  • Semaglutide: GLP-1 only (Wegovy, Ozempic)
  • Tirzepatide: GLP-1 and GIP (Zepbound, Mounjaro)
  • Both are weekly prescription injections
  • Similar side effects and contraindications

General information from Beauty Me MD, Westwood, Los Angeles. Not medical advice; your provider will advise you at a consultation.

Start with a free consultation

Tell us your goals and we'll recommend an honest, personalized plan.

Book a free consultation